Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

Also known as: Philadelphia Chromosome Positive Acute Lymphocytic Leukemia / Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL) / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) / Philadephia positive acute lymphoblastic leukemia / Ph+ Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia Ph Positive / Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) / PH+ ALL / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia / Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) / Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia / Ph+ Acute Lymphoblastic Leukemia (ALL) / Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia / Philadelphia Positive Acute Lymphoblastic Leukemia / Philadelphia-positive acute lymphoblastic leukemia / Philadelphia chromosome-positive acute lymphoblastic leukemia (morphologic abnormality) / Philadelphia chromosome-positive acute lymphoblastic leukemia (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12597Asciminib1Completed1
DB12597Asciminib1Recruiting1
DB09052Blinatumomab1Recruiting2
DB00987Cytarabine1Terminated1
DB01254Dasatinib1Completed2
DB01254Dasatinib1Recruiting1
DB01254Dasatinib1Terminated1
DB01254Dasatinib1Withdrawn1
DB01234Dexamethasone1Recruiting1
DB16185HQP13511Recruiting2
DB00619Imatinib1Completed1
DB00619Imatinib1Terminated1
DB18054Lisaftoclax1Recruiting1
DB11899MK-87761Terminated1
DB04868Nilotinib1Completed1
DB00635Prednisone1Recruiting1
DB05184XL2281Terminated1
DB01254Dasatinib1 / 2Completed1
DB04868Nilotinib1 / 2Completed3
DB06300Ponatinib1 / 2Completed1
DB08877Ruxolitinib1 / 2Completed1
DB09052Blinatumomab2Recruiting1
DB00531Cyclophosphamide2Terminated1
DB00531Cyclophosphamide2Unknown Status1
DB00987Cytarabine2Unknown Status1
DB01254Dasatinib2Completed3
DB01254Dasatinib2Recruiting1
DB01234Dexamethasone2Recruiting1
DB01234Dexamethasone2Unknown Status1
DB00099Filgrastim2Terminated1
DB01073Fludarabine2Terminated1
DB16185HQP13512Recruiting1
DB01177Idarubicin2Unknown Status1
DB00619Imatinib2Completed1
DB00619Imatinib2Recruiting1
DB00619Imatinib2Suspended1
DB00619Imatinib2Unknown Status1
DB05889Inotuzumab ozogamicin2Recruiting1
DB00563Methotrexate2Recruiting1
DB00563Methotrexate2Unknown Status1
DB00688Mycophenolate mofetil2Terminated1
DB04868Nilotinib2Completed1
DB06300Ponatinib2Completed1
DB08901Ponatinib2Completed1
DB08901Ponatinib2Recruiting2
DB08901Ponatinib2Suspended1
DB00635Prednisone2Recruiting1
DB00864Tacrolimus2Terminated1
DB11581Venetoclax2Recruiting1
DB00541Vincristine2Recruiting2
DB00541Vincristine2Unknown Status1
DB00135Tyrosine2 / 3Unknown Status1
DB09052Blinatumomab3Recruiting1
DB00987Cytarabine3Active Not Recruiting1
DB01254Dasatinib3Completed1
DB01234Dexamethasone3Active Not Recruiting1
DB16185HQP13513Recruiting1
DB00619Imatinib3Active Not Recruiting1
DB00619Imatinib3Recruiting2
DB00563Methotrexate3Active Not Recruiting1
DB08901Ponatinib3Active Not Recruiting1
DB08901Ponatinib3Recruiting1
DB00635Prednisone3Active Not Recruiting1
DB00541Vincristine3Active Not Recruiting1
DB01254Dasatinib4Unknown Status1
DB01234Dexamethasone4Unknown Status1
DB00619Imatinib4Recruiting1
DB00563Methotrexate4Unknown Status1
DB00635Prednisone4Unknown Status1
DB00987CytarabineNot AvailableRecruiting1
DB01254DasatinibNot AvailableRecruiting2
DB01234DexamethasoneNot AvailableRecruiting1
DB16185HQP1351Not AvailableNot Yet Recruiting1
DB05889Inotuzumab ozogamicinNot AvailableNot Yet Recruiting1
DB00563MethotrexateNot AvailableRecruiting2
DB00422MethylphenidateNot AvailableTerminated1
DB08901PonatinibNot AvailableActive Not Recruiting1
DB06300PonatinibNot AvailableApproved for Marketing1
DB08901PonatinibNot AvailableApproved for Marketing1
DB00635PrednisoneNot AvailableRecruiting1
DB00541VincristineNot AvailableRecruiting2